{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9410824", "DateCompleted": {"Year": "1997", "Month": "12", "Day": "01"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"Language": ["ger"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0015-8178", "JournalIssue": {"Volume": "115", "Issue": "24", "PubDate": {"Year": "1997", "Month": "Aug", "Day": "30"}}, "Title": "Fortschritte der Medizin", "ISOAbbreviation": "Fortschr Med"}, "ArticleTitle": "[Prediction: onset of improved mood after 2 weeks. Hypericum therapy in intermediate class depression. Interview by Dr. rer. nat. Till Uwe Keil].", "Pagination": {"StartPage": "49", "EndPage": "50", "MedlinePgn": "49-50"}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Adler", "ForeName": "M", "Initials": "M"}], "PublicationTypeList": ["Interview"], "VernacularTitle": "Vorhersage: Stimmungsaufhellung beginnt nach zwei Wochen. Hypericum-Therapie bei mittelgradigen Depressionen."}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Fortschr Med", "NlmUniqueID": "2984763R", "ISSNLinking": "0015-8178"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Serotonin Uptake Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Xanthenes"}, {"RegistryNumber": "5QD5427UN7", "NameOfSubstance": "Perylene"}, {"RegistryNumber": "9IKM0I5T1E", "NameOfSubstance": "Quercetin"}], "MeshHeadingList": [{"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Antidepressive Agents"}, {"QualifierName": ["classification", "drug therapy", "psychology"], "DescriptorName": "Depressive Disorder"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Hypericum"}, {"QualifierName": ["adverse effects", "analogs & derivatives", "therapeutic use"], "DescriptorName": "Perylene"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["adverse effects", "analogs & derivatives", "therapeutic use"], "DescriptorName": "Quercetin"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Selective Serotonin Reuptake Inhibitors"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Xanthenes"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1997", "Month": "8", "Day": "30", "Hour": "0", "Minute": "0"}, {"Year": "1997", "Month": "12", "Day": "31", "Hour": "0", "Minute": "1"}, {"Year": "1997", "Month": "8", "Day": "30", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9410824"]}}]}